-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| G795985 | 1254053-43-4 | Gilteritinib (ASP2215), 10mM in DMSO Gilteritinib (ASP2215), 10mM in DMSO |
C29H44N8O3 | |
| G883601 | 1254053-84-3 | Gilteritinib hemifumarate, ≥99% Gilteritinib hemifumarate, ≥99% |
C29H44N8O3 0.5C4H4O4 | |
| G882232 | 147419-93-0 | Ginsenoside Rg6, 98% Ginsenoside Rg6, 98% |
C42H70O12 | |
| G884732 | 105558-26-7 | Ginsenoside Rh3, ≥98% Ginsenoside Rh3, ≥98% |
C36H60O7 | |
| G879333 | 364779-15-7 | Ginsenoside Rk3, 98% Ginsenoside Rk3, 98% |
C36H60O8 | |
| G878808 | 497833-27-9 | Givinostat, 98% Givinostat, 98% |
C24H27N3O4 | |
| G872288 | 732302-99-7 | Givinostat (ITF2357), 99% Givinostat (ITF2357), 99% |
C24H27N3O4·HCl·H2O | |
| G880767 | 199657-29-9 | Givinostat hydrochloride, 98% Givinostat hydrochloride, 98% |
C24H28ClN3O4 | |
| G882274 | 1459687-96-7 | GJ103 sodium salt , ≥99% GJ103 sodium salt , ≥99% |
C16H13N4NaO3S | |
| G861044 | 1025015-40-0 | GK921, >98% GK921, >98% |
C21H20N4O | |
| G793182 | 1025015-40-0 | GK921, 10mM in DMSO GK921, 10mM in DMSO |
C21H20N4O | |
| G872745 | 1218942-37-0 | GKT137831, 99% GKT137831, 99% |
C21H19ClN4O2 | |
| G795189 | 65513-72-6 | Glafenine hydrochloride, 10mM in DMSO Glafenine hydrochloride, 10mM in DMSO |
C19H18Cl2N2O4 | |
| G877962 | 65513-72-6 | Glafenine hydrochloride, ≥98% Glafenine hydrochloride, ≥98% |
C19H18Cl2N2O4 | |
| G797459 | 1095173-27-5 | Glasdegib (PF-04449913), 10mM in DMSO Glasdegib (PF-04449913), 10mM in DMSO |
C21H22N6O | |
| G873144 | 1095173-27-5 | Glasdegib (PF-04449913), 99% Glasdegib (PF-04449913), 99% |
C21H22N6O | |
| G795082 | 1365970-03-1 | Glecaprevir, 10mM in DMSO Glecaprevir, 10mM in DMSO |
C38H46F4N6O9S | |
| G873456 | 1365970-03-1 | Glecaprevir, 98% Glecaprevir, 98% |
C38H46F4N6O9S | |
| G884496 | 1123838-51-6 | Glesatinib hydrochloride, ≥98% Glesatinib hydrochloride, ≥98% |
C31H28ClF2N5O3S2 | |
| G792287 | 875337-44-3 | Glesatinib (MGCD265), 10mM in DMSO Glesatinib (MGCD265), 10mM in DMSO |
C26H20FN5O2S2 |
